ESC 365 - Assessing risk and optimizing outcomes – What do the data tell us?

Open Access

Assessing risk and optimizing outcomes – What do the data tell us?

Session: Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2

Topic: Treatment

Speaker: Professor V. McLaughlin (Ann Arbor, US)

Sponsored by Actelion Pharmaceuticals Ltd

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Vallerie McLaughlin

University of Michigan, Ann Arbor (United States of America)

5 presentations

0 follower

4 more presentations in this session

Introduction - Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2

Speaker: Professor A. Torbicki (Otwock, PL)

From risk assessment to treatment strategy – A patient case.

Speaker: Doctor F. Bauer (Rouen, FR)

Panel discussion - Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2.

Speaker: Professor S. Rosenkranz (Cologne, DE) Professor A. Torbicki (Otwock, PL) Professor V. McLaughlin (Ann Arbor, US) Doctor F. Bauer (Rouen, FR)

Closing remarks - Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2.

Speaker: Professor S. Rosenkranz (Cologne, DE)

Access the full session

Achieve more in pulmonary arterial hypertension – Translating insights into patient benefits, Volume 2

Speakers: Professor V. McLaughlin, Professor A. Torbicki, Doctor F. Bauer, Professor S. Rosenkranz, Professor A. Torbicki...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources